Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sanofi’s dupilumab receives EAMS positive scientific opinion from UK MHRA for AD

pharmaceutical-technologyMarch 17, 2017

Tag: Sanofi , EAMS

PharmaSources Customer Service